Latest Hansen Medical (HNSN) Headlines
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
War On Poachers to Intensify
All Africa Global Media - Wed Feb 26, 12:31AM CST
THE government will use all resources at its disposal to improve anti-poaching operations and increase the number of game rangers to protect the country's wildlife from total extinction, Natural Resources and Tourism Minister Lazaro Nyalandu has said.
Hansen Medical Reports Fourth Quarter and Full-Year 2013 Results
Marketwire - Thu Feb 20, 3:05PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2013.
Hansen Medical to Present at the 34th Annual Cowen and Company Healthcare Conference
Marketwire - Tue Feb 18, 5:00PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported that Peter J. Mariani, Chief Financial Officer, is scheduled to present at the 34th Annual Cowen and Company Healthcare Conference. The conference is being held March 2 - 5, 2014 at The Boston Marriott Copley Place in Boston, Massachusetts. Hansen Medical is scheduled to present on Tuesday, March 4, 2014 at 8:00 a.m. Eastern Time.
Bauer Performance Sports to Acquire Easton Baseball/Softball for US $330 Million
Marketwire Canada - Thu Feb 13, 12:00PM CST
Bauer Performance Sports Ltd. (TSX:BAU) ("BPS" or the "Company"), a leading developer and manufacturer of high performance sports equipment and apparel, has entered into a definitive asset purchase agreement with Easton-Bell Sports to acquire the Easton Baseball/Softball business for US $330 million in an all-cash transaction, subject to a working capital adjustment. The purchase agreement was unanimously approved by both companies' boards of directors and is expected to close in approximately 30-60 days, subject to regulatory approvals and other customary closing conditions.
Why Hansen Medical, Inc. Was Today's Biggest Winner
David Williamson, The Motley Fool - Motley Fool - Tue Feb 11, 5:45PM CST
In this video from Tuesday's Market Checkup , Motley Fool health care analyst David Williamson takes investors through the biggest investing stories in the health care space today. Shares of Hansen Medical shot up 20% today, on news that the...
Why Cadence Pharmaceuticals, Relypsa, and Hansen Medical Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Tue Feb 11, 4:15PM CST
You could certainly say that Janet Yellen met or bested expectations in her first testimony to Congress as Federal Reserve chairwoman today, as evidenced by the broad-based rally in the S&P 500 . As my Foolish colleague Travis Hoium noted...
Why Hansen Medical Inc. Shares Soared
Sean Williams, The Motley Fool - Motley Fool - Tue Feb 11, 1:00PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Hansen Medical , a designer of medical...
Why Hansen Medical (HNSN) Is Soaring Today
at The Street - Tue Feb 11, 11:25AM CST
Hansen Medical (HNSN) soars after the medical robotics manufacturer announced that it has received FDA clearance for its Magellan 6Fr Robotic Catheter, which has a smaller diameter than the Magellan 9Fr Robotic Catheter. The clearance mandates that...
Traders Get Bullish on Shares of Hansen Medical, Shares Up 15.6% (HNSN)
Comtex SmarTrend(R) - Tue Feb 11, 10:12AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing low-priced stocks, up 15.6% to $2.58 on 10.2x average daily volume. Hansen Medical has traded 3.7 million shares thus far today, vs. average volume of 356,000 shares per day. The stock has outperformed the Dow (15.6% to the Dow's 0.5%) and outperformed the S&P 500 (15.6% to the S&P's 0.4%) during today's trading.
Hansen Medical Announces FDA Clearance of the Magellan(TM) 6Fr Robotic Catheter
Marketwire - Tue Feb 11, 7:45AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its smaller diameter Magellan(TM) 6Fr Robotic Catheter for peripheral vascular interventions.
Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company
Marketwire - Mon Feb 10, 3:05PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that current Board member Chris Lowe has been appointed Interim Chief Executive Officer effective yesterday. Mr. Lowe succeeds Bruce J. Barclay, President and CEO since 2010. The Board of Directors has retained Russell Reynolds Associates to conduct a search for a new CEO.
Hansen Medical Announces Fourth Quarter and Fiscal Year 2013 Results Conference Call
Marketwire - Fri Feb 07, 8:29AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will release its financial and operating results for the fourth quarter and full year ended December 31, 2013 after market close on Thursday, February 20, 2014.
Concise Analysis on the International Surgical Robot Market - Forecasts to 2019
M2 - Fri Jan 31, 5:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/wlnv2r/surgical_robot) has announced the addition of a new report "Concise Analysis on the International Surgical Robot Market - Forecasts to 2019" to their offering. Existing open surgery can be replaced in large part by robotic minimally invasive surgery (MIS). Minimally invasive robotic surgery, new robotic radiation treatment, and emerging robotic surgical approaches complement existing surgery techniques. Soon, all surgery will be undertakes with at least come aspects of robotic surgery replacing or complementing open surgery. During a robot assisted surgical procedure, the patient-side cart is positioned next to the operating table with the electromechanical arms arranged to provide access to the initial ports selected by the surgeon. When a surgeon needs to change an instrument the instrument is withdrawn from the surgical field using the controls at the console. This is done many times during an operation. The companies that get an early foothold in the market have significant strategic advantage. The robotic surgical technique benefits hospitals by reducing the length of patient stays, thereby enabling better cost management. This factor is driving demand for surgery robot systems. Since robotics provide surgeons with a precise, repeatable and controlled ability to perform procedures in tight spaces, they are increasingly in demand. Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Surgical robot device markets at $3.2 billion in 2012 are anticipated to reach $19.96 billion by 2019 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds. Key Topics Covered: Surgical Robot Executive Summary 1. Surgical Robots Market Description and Market Dynamics 2. Surgical Robot Market Shares and Forecasts 3. Surgical Robots Product Description 4. Medical Robot Technology 5. Surgical Robots Company Description Companies Mentioned: - Accuray - Corindus - Curexo Technology Corporation - Freehand 2010 - Hansen Medical - Healthcare Robotics - InTouch Health - Intuitive Surgical - MAKO Surgical - Medrobotics - Otto Bock HealthCare - Restoration Robotics - Titan Medical - UC Berkeley - Vecna Robotics - iRobot For more information visit http://www.researchandmarkets.com/research/wl...ical_robot
Hansen Medical to Exhibit Magellan(TM) Robotic System at Upcoming CACVS & LINC Meetings in Europe
Marketwire - Thu Jan 23, 7:00AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at two upcoming interventional meetings in Europe. Hansen will be exhibiting Magellan at Booth 25 for the Controversies and Updates in Vascular Surgery (CACVS) Meeting in Paris, France from January 23 - 25; and at Booth 4 for the Leipzig Interventional Course (LINC) in Leipzig, Germany from January 28 - 31.
Hot Stock: Hansen Medical, Shares Gain 6.5% (HNSN)
Comtex SmarTrend(R) - Wed Jan 22, 10:13AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing low-priced stocks, up 6.5% to $2.29 on 1.2x average daily volume. Thus far today, Hansen Medical has traded 367,000 shares, vs. average volume of 300,000 shares per day. The stock has outperformed the Dow (6.5% to the Dow's -0.4%) and outperformed the S&P 500 (6.5% to the S&P's -0.1%) during today's trading.
Hansen Medical Inc to exhibit and utiliise the Magellan Robotic System at 26th Annual International Symposium on Endovascular Therapy in Miami
M2 - Tue Jan 21, 4:28AM CST
Intravascular robotics company Hansen Medical Inc (NASDAQ:HNSN) reported on Monday that it will exhibit the Magellan Robotic System at the 26th Annual International Symposium on Endovascular Therapy (ISET) from 18 January 2014 - 22 January 2014 at the Fontainebleau Miami Beach Hotel in Miami, FL.
Hansen Medical's Magellan(TM) Robotic System to Be Featured in Three Live Cases at 26th Annual International Symposium on Endovascular Therapy
Marketwire - Mon Jan 20, 5:00AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in Intravascular Robotics, today announced that Dr. Barry Katzen, founder and Medical Director of Baptist Cardiac & Vascular Institute (Baptist Hospital of Miami), is scheduled to utilize the Magellan(TM) Robotic System in three live endovascular cases at the 26th Annual International Symposium on Endovascular Therapy (ISET), from January 18th - 22nd at the Fontainebleau Miami Beach Hotel in Miami, FL. The Company will also be exhibiting the Magellan Robotic System during the meeting at Booth 603.
Competition In Lethbridge's Feed Market Drives Prices Lower
Brandon Logan, Commodity News Service Canada - Commodity News Service Canada, Inc. - Thu Jan 16, 2:39PM CST
Competition for Lethbridge's marketplace is heating up, as feed wheat and barley are nearly priced identically, leading to further declines in both markets.
Hansen Medical Up 5.9%, Shares Break Through Resistance (HNSN)
Comtex SmarTrend(R) - Tue Jan 14, 10:42AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing low-priced stocks, up 5.9% to $1.97 on 1.9x average daily volume. Hansen Medical has traded 490,000 shares thus far today, vs. average volume of 253,000 shares per day. The stock has outperformed the Dow (5.9% to the Dow's 0.4%) and outperformed the S&P 500 (5.9% to the S&P's 0.7%) during today's trading.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
War On Poachers to Intensify
All Africa Global Media - Wed Feb 26, 12:31AM CST
THE government will use all resources at its disposal to improve anti-poaching operations and increase the number of game rangers to protect the country's wildlife from total extinction, Natural Resources and Tourism Minister Lazaro Nyalandu has said.
Hansen Medical Reports Fourth Quarter and Full-Year 2013 Results
Marketwire - Thu Feb 20, 3:05PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2013.
Hansen Medical to Present at the 34th Annual Cowen and Company Healthcare Conference
Marketwire - Tue Feb 18, 5:00PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported that Peter J. Mariani, Chief Financial Officer, is scheduled to present at the 34th Annual Cowen and Company Healthcare Conference. The conference is being held March 2 - 5, 2014 at The Boston Marriott Copley Place in Boston, Massachusetts. Hansen Medical is scheduled to present on Tuesday, March 4, 2014 at 8:00 a.m. Eastern Time.
Bauer Performance Sports to Acquire Easton Baseball/Softball for US $330 Million
Marketwire Canada - Thu Feb 13, 12:00PM CST
Bauer Performance Sports Ltd. (TSX:BAU) ("BPS" or the "Company"), a leading developer and manufacturer of high performance sports equipment and apparel, has entered into a definitive asset purchase agreement with Easton-Bell Sports to acquire the Easton Baseball/Softball business for US $330 million in an all-cash transaction, subject to a working capital adjustment. The purchase agreement was unanimously approved by both companies' boards of directors and is expected to close in approximately 30-60 days, subject to regulatory approvals and other customary closing conditions.
Why Hansen Medical, Inc. Was Today's Biggest Winner
David Williamson, The Motley Fool - Motley Fool - Tue Feb 11, 5:45PM CST
In this video from Tuesday's Market Checkup , Motley Fool health care analyst David Williamson takes investors through the biggest investing stories in the health care space today. Shares of Hansen Medical shot up 20% today, on news that the...
Why Cadence Pharmaceuticals, Relypsa, and Hansen Medical Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Tue Feb 11, 4:15PM CST
You could certainly say that Janet Yellen met or bested expectations in her first testimony to Congress as Federal Reserve chairwoman today, as evidenced by the broad-based rally in the S&P 500 . As my Foolish colleague Travis Hoium noted...
Why Hansen Medical Inc. Shares Soared
Sean Williams, The Motley Fool - Motley Fool - Tue Feb 11, 1:00PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Hansen Medical , a designer of medical...
Why Hansen Medical (HNSN) Is Soaring Today
at The Street - Tue Feb 11, 11:25AM CST
Hansen Medical (HNSN) soars after the medical robotics manufacturer announced that it has received FDA clearance for its Magellan 6Fr Robotic Catheter, which has a smaller diameter than the Magellan 9Fr Robotic Catheter. The clearance mandates that...
Traders Get Bullish on Shares of Hansen Medical, Shares Up 15.6% (HNSN)
Comtex SmarTrend(R) - Tue Feb 11, 10:12AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing low-priced stocks, up 15.6% to $2.58 on 10.2x average daily volume. Hansen Medical has traded 3.7 million shares thus far today, vs. average volume of 356,000 shares per day. The stock has outperformed the Dow (15.6% to the Dow's 0.5%) and outperformed the S&P 500 (15.6% to the S&P's 0.4%) during today's trading.
Hansen Medical Announces FDA Clearance of the Magellan(TM) 6Fr Robotic Catheter
Marketwire - Tue Feb 11, 7:45AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its smaller diameter Magellan(TM) 6Fr Robotic Catheter for peripheral vascular interventions.
Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company
Marketwire - Mon Feb 10, 3:05PM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that current Board member Chris Lowe has been appointed Interim Chief Executive Officer effective yesterday. Mr. Lowe succeeds Bruce J. Barclay, President and CEO since 2010. The Board of Directors has retained Russell Reynolds Associates to conduct a search for a new CEO.
Hansen Medical Announces Fourth Quarter and Fiscal Year 2013 Results Conference Call
Marketwire - Fri Feb 07, 8:29AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will release its financial and operating results for the fourth quarter and full year ended December 31, 2013 after market close on Thursday, February 20, 2014.
Concise Analysis on the International Surgical Robot Market - Forecasts to 2019
M2 - Fri Jan 31, 5:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/wlnv2r/surgical_robot) has announced the addition of a new report "Concise Analysis on the International Surgical Robot Market - Forecasts to 2019" to their offering. Existing open surgery can be replaced in large part by robotic minimally invasive surgery (MIS). Minimally invasive robotic surgery, new robotic radiation treatment, and emerging robotic surgical approaches complement existing surgery techniques. Soon, all surgery will be undertakes with at least come aspects of robotic surgery replacing or complementing open surgery. During a robot assisted surgical procedure, the patient-side cart is positioned next to the operating table with the electromechanical arms arranged to provide access to the initial ports selected by the surgeon. When a surgeon needs to change an instrument the instrument is withdrawn from the surgical field using the controls at the console. This is done many times during an operation. The companies that get an early foothold in the market have significant strategic advantage. The robotic surgical technique benefits hospitals by reducing the length of patient stays, thereby enabling better cost management. This factor is driving demand for surgery robot systems. Since robotics provide surgeons with a precise, repeatable and controlled ability to perform procedures in tight spaces, they are increasingly in demand. Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Surgical robot device markets at $3.2 billion in 2012 are anticipated to reach $19.96 billion by 2019 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds. Key Topics Covered: Surgical Robot Executive Summary 1. Surgical Robots Market Description and Market Dynamics 2. Surgical Robot Market Shares and Forecasts 3. Surgical Robots Product Description 4. Medical Robot Technology 5. Surgical Robots Company Description Companies Mentioned: - Accuray - Corindus - Curexo Technology Corporation - Freehand 2010 - Hansen Medical - Healthcare Robotics - InTouch Health - Intuitive Surgical - MAKO Surgical - Medrobotics - Otto Bock HealthCare - Restoration Robotics - Titan Medical - UC Berkeley - Vecna Robotics - iRobot For more information visit http://www.researchandmarkets.com/research/wl...ical_robot
Hansen Medical to Exhibit Magellan(TM) Robotic System at Upcoming CACVS & LINC Meetings in Europe
Marketwire - Thu Jan 23, 7:00AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at two upcoming interventional meetings in Europe. Hansen will be exhibiting Magellan at Booth 25 for the Controversies and Updates in Vascular Surgery (CACVS) Meeting in Paris, France from January 23 - 25; and at Booth 4 for the Leipzig Interventional Course (LINC) in Leipzig, Germany from January 28 - 31.
Hot Stock: Hansen Medical, Shares Gain 6.5% (HNSN)
Comtex SmarTrend(R) - Wed Jan 22, 10:13AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing low-priced stocks, up 6.5% to $2.29 on 1.2x average daily volume. Thus far today, Hansen Medical has traded 367,000 shares, vs. average volume of 300,000 shares per day. The stock has outperformed the Dow (6.5% to the Dow's -0.4%) and outperformed the S&P 500 (6.5% to the S&P's -0.1%) during today's trading.
Hansen Medical Inc to exhibit and utiliise the Magellan Robotic System at 26th Annual International Symposium on Endovascular Therapy in Miami
M2 - Tue Jan 21, 4:28AM CST
Intravascular robotics company Hansen Medical Inc (NASDAQ:HNSN) reported on Monday that it will exhibit the Magellan Robotic System at the 26th Annual International Symposium on Endovascular Therapy (ISET) from 18 January 2014 - 22 January 2014 at the Fontainebleau Miami Beach Hotel in Miami, FL.
Hansen Medical's Magellan(TM) Robotic System to Be Featured in Three Live Cases at 26th Annual International Symposium on Endovascular Therapy
Marketwire - Mon Jan 20, 5:00AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in Intravascular Robotics, today announced that Dr. Barry Katzen, founder and Medical Director of Baptist Cardiac & Vascular Institute (Baptist Hospital of Miami), is scheduled to utilize the Magellan(TM) Robotic System in three live endovascular cases at the 26th Annual International Symposium on Endovascular Therapy (ISET), from January 18th - 22nd at the Fontainebleau Miami Beach Hotel in Miami, FL. The Company will also be exhibiting the Magellan Robotic System during the meeting at Booth 603.
Competition In Lethbridge's Feed Market Drives Prices Lower
Brandon Logan, Commodity News Service Canada - Commodity News Service Canada, Inc. - Thu Jan 16, 2:39PM CST
Competition for Lethbridge's marketplace is heating up, as feed wheat and barley are nearly priced identically, leading to further declines in both markets.
Hansen Medical Up 5.9%, Shares Break Through Resistance (HNSN)
Comtex SmarTrend(R) - Tue Jan 14, 10:42AM CST
Hansen Medical (NASDAQ:HNSN) is one of today's best performing low-priced stocks, up 5.9% to $1.97 on 1.9x average daily volume. Hansen Medical has traded 490,000 shares thus far today, vs. average volume of 253,000 shares per day. The stock has outperformed the Dow (5.9% to the Dow's 0.4%) and outperformed the S&P 500 (5.9% to the S&P's 0.7%) during today's trading.
